Purification of a polysaccharide from Boschniakia rossica and its synergistic antitumor effect combined with 5-Fluorouracil

► Boschniakia rossica is a traditional Chinese herbal medicine. ► A polysaccharide was prepared and its chemical analysis was preliminarily made. ► BRP alone or combined with 5-FU could inhibit S180 tumor growth. ► Damage to the immune system caused by 5-FU in S180-bearing mice was mitigated by BRP....

Full description

Saved in:
Bibliographic Details
Published inCarbohydrate polymers Vol. 89; no. 1; pp. 31 - 35
Main Authors Wang, Zhenghui, Wu, Baojun, Zhang, Xianghong, Xu, Min, Chang, Huimin, Lu, Xiaoyun, Ren, Xiaoyong
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 05.06.2012
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:► Boschniakia rossica is a traditional Chinese herbal medicine. ► A polysaccharide was prepared and its chemical analysis was preliminarily made. ► BRP alone or combined with 5-FU could inhibit S180 tumor growth. ► Damage to the immune system caused by 5-FU in S180-bearing mice was mitigated by BRP. ► BRP combined with 5-FU presented synergistic effects on antitumor activity in S180 tumor bearing mice. Current study we purified a polysaccharide (BRP) from Boschniakia rossica and the antitumor effects of BRP alone or combined with 5-Fluorouracil (5-FU) was examined in S180 tumor bearing mice by intragastric administration. The high performance size-exclusion chromatography (HPGEC) analysis showed that BRP was a homogeneous polysaccharide and had a molecular weight of 2.2×104Da. Total carbohydrate content in BRP was determined to be 96.9%, without the presence of protein and nucleic acid. BRP alone or combined with 5-FU could significantly inhibit Sarcoma-180 (S180) tumor growth and increase the spleen index in a dose-dependent manner. Meanwhile a synergistic effect was observed in boosting various immunity functions when the tumor bearing mice receiving BRP plus 5-FU administration, such as stimulating lymphocytes proliferation, increasing NK cell cytotoxicity, enhancing serum interleukin-2 (IL-2) and interferon-gamma (TNF-γ) secretion, as well as augmenting CD4+ and CD8+ spleen T lymphocytes subsets. The results showed that BRP combined with 5-FU presented synergistic effects on antitumor activity in tumor bearing mice. In conclusion, the combination of BRP may boost the suppressed immunity in tumor bearing mice subject to 5-FU chemotherapy, and could serve as a new, promising approach for cancer treatment.
Bibliography:http://dx.doi.org/10.1016/j.carbpol.2012.02.024
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0144-8617
1879-1344
1879-1344
DOI:10.1016/j.carbpol.2012.02.024